Wenning, Gregor K.

Second consensus statement on the diagnosis of multiple system atrophy

Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 3,140

The diagnosis of Parkinson’s disease

Tolosa, E., Wenning, G., & Poewe, W. (2006) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 902

Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia

Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia

Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments

Cited by 697

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Moss, D. J. H., Pardiñas, A. F., Langbehn, D., Lo, K., Leavitt, B. R., Roos, R., Durr, A., Mead, S., Coleman, A., Santos, R. D., et al. (2017) · The Lancet Neurology

Genetic Neurodegenerative DiseasesGenetic Associations and Epidemiology

Cited by 312

Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study

Wenning, G. K., Kiechl, S., Seppi, K., Müller, J., Högl, B., Saletu, M., Rungger, G., Gasperi, A., Willeit, J., & Poewe, W. (2005) · The Lancet Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 302

Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons

Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 272

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Kouri, N., Ross, O. A., Dombroski, B., Younkin, C. S., Serie, D. J., Soto-Ortolaza, A., Baker, M., Finch, N. C. A., Yoon, H., Kim, J., et al. (2015) · Nature Communications

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 219

Oxidative Stress in Transgenic Mice with Oligodendroglial α-Synuclein Overexpression Replicates the Characteristic Neuropathology of Multiple System Atrophy

Stefanova, N., Reindl, M., Neumann, M., Haass, C., Poewe, W., Kahle, P. J., & Wenning, G. K. (2005) · The American Journal of Pathology

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 208

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression

Müller, J., Kemmler, G., Wissel, J., Schneider, A., Voller, B., Grossmann, J., Diez, J., Homann, N., Wenning, G. K., Schnider, P., et al. (2002) · Journal of Neurology

Botulinum Toxin and Related Neurological DisordersDeep Brain Stimulation and Movement Disorders

Cited by 207

Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy

Brenneis, C., Seppi, K., Schocke, M. F., Müller, J., Luginger, E., Bösch, S., Löscher, W. N., Büchel, C., Poewe, W., & Wenning, G. K. (2003) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 167

Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts

Fellner, L., Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2011) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 162

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

Peball, M., Krismer, F., Knaus, H., Djamshidian, A., Werkmann, M., Carbone, F., Ellmerer, P., Heim, B., Marini, K., Valent, D., et al. (2020) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsCannabis and Cannabinoid Research

Cited by 123

Myeloperoxidase Inhibition Ameliorates Multiple System Atrophy-Like Degeneration in a Transgenic Mouse Model

Stefanova, N., Georgievska, B., Eriksson, H., Poewe, W., & Wenning, G. K. (2012) · Neurotoxicity Research

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 111

Glial cell death induced by overexpression of α‐synuclein

Stefanova, N., Klimaschewski, L., Poewe, W., Wenning, G. K., & Reindl, M. (2001) · Journal of Neuroscience Research

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 93

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure

Stemberger, S., Poewe, W., Wenning, G. K., & Stefanova, N. (2010) · Experimental Neurology

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 83

Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm

Fanciulli, A., Strano, S., Ndayisaba, J. P., Goebel, G., Gioffrè, L., Rizzo, M., Colosimo, C., Caltagirone, C., Poewe, W., Wenning, G. K., et al. (2014) · Journal of Neurology

Cardiovascular Syncope and Autonomic DisordersParkinson's Disease Mechanisms and Treatments

Cited by 67

Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies

Refolo, V., Bez, F., Polissidis, A., Kuzdas-Wood, D., Sturm, E., Kamaratou, M., Poewe, W., Stefanis, L., Angela Cenci, M., Romero-Ramos, M., et al. (2018) · Acta Neuropathologica Communications

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 67

Investigation of autonomic function in idiopathic REM sleep behavior disorder

Frauscher, B., Nomura, T., Duerr, S., Ehrmann, L., Gschliesser, V., Wenning, G. K., Wolf, E., Inoue, Y., Högl, B., & Poewe, W. (2012) · Journal of Neurology

Parkinson's Disease Mechanisms and TreatmentsCardiovascular Syncope and Autonomic Disorders

Cited by 65

Topography of Dopamine Transporter Availability in Progressive Supranuclear Palsy: A Voxelwise [123I]β-CIT SPECT Analysis

Seppi, K., Scherfler, C., Donnemiller, E., Virgolini, I., Schocke, M. F. H., Goebel, G., Mair, K. J., Boesch, S., Brenneis, C., Wenning, G. K., et al. (2006) · Archives of Neurology

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 64

Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [ 11 C ] PBR28 and Machine Learning Analysis

Jucaite, A., Cselényi, Z., Kreisl, W. C., Rabiner, E. A., Varrone, A., Carson, R. E., Rinne, J. O., Savage, A., Schou, M., Johnström, P., et al. (2022) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 43